Top Clinical Trials companies in Israel by Revenue

This ranking features the top 11 Clinical Trials companies in Israel ranked by Revenue, totalling a Revenue of USD 39.20 M, for January 15, 2025.

Israel

Clinical Trials
Revenue
#
Name
Revenue
 Reported Date
Stock Price
Change
 Price (30 days) Country
1
CGEN.TA

Compugen Ltd.

1

CGEN.TA
USD 33.46 M
Dec. 31, 2023 USD 1.85 10.75%

Israel
2
BLRX.TA

BioLineRx Ltd.

2

BLRX.TA
USD 4.80 M
Dec. 31, 2023 USD 0.01 -11.50%

Israel
3
CANF.TA

Can-Fite BioPharma Ltd.

3

CANF.TA
USD 743.00 K
Dec. 31, 2023 USD 0.01 0.04%

Israel
4
PPBT.TA

Purple Biotech Ltd.

4

PPBT.TA
USD 195.80 K
Dec. 31, 2023 USD 0.02 -1.36%

Israel
5
ENTX

Entera Bio Ltd.

5

ENTX
USD 0.00
Dec. 31, 2023 USD 2.36 -1.67%

Israel
6
GLMD

Galmed Pharmaceuticals Ltd.

6

GLMD
USD 0.00
Dec. 31, 2023 USD 2.82 -2.08%

Israel
7
NRSN

NeuroSense Therapeutics Ltd.

7

NRSN
USD 0.00
Dec. 31, 2023 USD 1.03 -0.96%

Israel
8
PRFX

PainReform Ltd.

8

PRFX
USD 0.00
Dec. 31, 2023 USD 2.74 -3.52%

Israel
9
CMMB

Chemomab Therapeutics Ltd.

9

CMMB
USD 0.00
Dec. 31, 2023 USD 1.90 -4.04%

Israel
10
DRTS

Alpha Tau Medical Ltd.

10

DRTS
USD 0.00
Dec. 31, 2023 USD 4.00 8.11%

Israel
11
ENLV.TA

Enlivex Therapeutics Ltd.

11

ENLV.TA
USD 0.00
Dec. 31, 2023 USD 1.16 -2.88%

Israel
Frequently Asked Questions
  • Which Clinical Trials company in Israel has the highest Revenue ?

    The Clinical Trials company in Israel with the highest Revenue is Compugen Ltd. (Tel Aviv Stock Exchange: CGEN.TA) at USD 33.46 M.

  • Which Clinical Trials company in Israel has the lowest Revenue ?

    The Clinical Trials company in Israel with the lowest Revenue is Enlivex Therapeutics Ltd. (Tel Aviv Stock Exchange: ENLV.TA) at USD 0.00.